Qing Qi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Qing Qi has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Jing Zhou
Department of Obstetrics and Gynecology, Southern Medical University Nanfang Hospital, Guangzhou, Guangdong, China
2 shared publications- Ling Wang
Department of Obstetrics and Reproductive Immunology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China
2 shared publications Ziqin Chen
College of Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China
2 shared publications- Binbin Zhao
School of Basic Medical Sciences, Hubei University of Chinese Medicine, Wuhan 430065, China; Hubei Shizhen Laboratory, Wuhan 430061, China
1 shared publication Bing Wu
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; School of Pharmacy, University of Chinese Academy of Sciences, Beijing, China
1 shared publication- Bingsheng Zhou
Chinese Academy of Sciences
1 shared publication
Latest Publications
- Open Access
- 31 August 2025
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Drug Discoveries & Therapeutics
- Vol. 19 (4) , 220-229
Serum lipid levels serve as predictors for osteoporosis or osteopenia in postmenopausal women: A meta-analysis of observational studies
This meta-analysis summarizes the differences in serum lipid levels among postmenopausal women with osteopenia, osteoporosis, and normal bone mass, aiming to establish reliable lipid markers for predicting bone loss in postmenopausal women. Relevant literature published up to March 21, 2024, was sourced from databases including PubMed, Embase, Web of Science, and the Cochrane Library. Following a thorough evaluation in accordance with established inclusion and exclusion criteria, the meta-analysis incorporated 14 studies, involving a total of 12,974 postmenopausal women. The weighted mean deviation (WMD) and 95% confidence intervals (CIs) were conducted by RevMan 5.4 software. The findings indicated that serum triglyceride (TG) concentrations were significantly lower in osteopenia (WMD = -6.82, 95% CI: -9.80 to -3.83, P = 0.05, I2 = 42%) and osteoporosis (WMD = -10.28, 95% CI: -14.51 to -6.04, P < 0.001, I2 = 45%) women compared to their normal counterparts. In addition, serum high-density lipoprotein cholesterol (HDL-C) levels were notably elevated in osteoporosis women (WMD = 1.66, 95% CI: 0.75 to 2.57, P = 0.0004, I2 = 43%). However, no significant discrepancies were found in total cholesterol and low-density lipoprotein cholesterol levels among postmenopausal women with bone loss. Sensitivity analysis showed that the results of the meta-analysis were reliable. Egger's test showed no publication bias in the included studies. Consequently, our meta-analysis shows that low serum TG levels predict the onset of osteopenia in postmenopausal women, while high serum HDL-C levels suggest a potential risk for osteoporosis.
- 31 August 2025
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Drug Discoveries & Therapeutics
- Vol. 19 (4) , 220-229
Open AccessSerum lipid levels serve as predictors for osteoporosis or osteopenia in postmenopausal women: A meta-analysis of observational studies
This meta-analysis summarizes the differences in serum lipid levels among postmenopausal women with osteopenia, osteoporosis, and normal bone mass, aiming to establish reliable lipid markers for predicting bone loss in postmenopausal women. Relevant literature published up to March 21, 2024, was sourced from databases including PubMed, Embase, Web of Science, and the Cochrane Library. Following a thorough evaluation in accordance with established inclusion and exclusion criteria, the meta-analysis incorporated 14 studies, involving a total of 12,974 postmenopausal women. The weighted mean deviation (WMD) and 95% confidence intervals (CIs) were conducted by RevMan 5.4 software. The findings indicated that serum triglyceride (TG) concentrations were significantly lower in osteopenia (WMD = -6.82, 95% CI: -9.80 to -3.83, P = 0.05, I2 = 42%) and osteoporosis (WMD = -10.28, 95% CI: -14.51 to -6.04, P < 0.001, I2 = 45%) women compared to their normal counterparts. In addition, serum high-density lipoprotein cholesterol (HDL-C) levels were notably elevated in osteoporosis women (WMD = 1.66, 95% CI: 0.75 to 2.57, P = 0.0004, I2 = 43%). However, no significant discrepancies were found in total cholesterol and low-density lipoprotein cholesterol levels among postmenopausal women with bone loss. Sensitivity analysis showed that the results of the meta-analysis were reliable. Egger's test showed no publication bias in the included studies. Consequently, our meta-analysis shows that low serum TG levels predict the onset of osteopenia in postmenopausal women, while high serum HDL-C levels suggest a potential risk for osteoporosis.
- 21 January 2024
- Published by Elsevier in Life Sciences
- Vol. 340, 122419
Overview of tumor immunotherapy based on approved drugs
- 21 January 2024
- Published by Elsevier in Life Sciences
- Vol. 340, 122419
Overview of tumor immunotherapy based on approved drugs
- 1 July 2021
- Published by Elsevier in Pharmacological Research
- Vol. 169, 105678
Triptolide analog LLDT-8 ameliorates psoriasis-like dermatitis in BALB/c mice via suppressing the IL-36α signaling pathway
- 1 July 2021
- Published by Elsevier in Pharmacological Research
- Vol. 169, 105678
Triptolide analog LLDT-8 ameliorates psoriasis-like dermatitis in BALB/c mice via suppressing the IL-36α signaling pathway